Standardized care management ensures similar survival rates in HIV-positive and HIV-negative patients with hepatocellular carcinoma

Journal of Acquired Immune Deficiency Syndromes

Volumn 61, Issue 5, 2012, Pages 581-587

  Lim, Chetana ^a   Goutte, Nathalie ^a   Gervais, Anne ^b   Vullierme, Marie Pierre ^a   Valla, Dominique C ^a   Degos, Françoise ^a   Farges, Olivier ^a  

^a BEAUJON HOSPITAL   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

Acquired immunodeficiency syndrome; Cancer screening; Hepatocellular carcinoma; Interdisciplinary communication; Medication adherence

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT;

ADULT; ALCOHOL ABUSE; ALPHA FETOPROTEIN BLOOD LEVEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIATIVE THERAPY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SURVIVAL RATE; AGED; CASE CONTROL STUDY; COHORT ANALYSIS; FRANCE; KAPLAN MEIER METHOD; LIVER TUMOR; MORTALITY; PATIENT CARE; STANDARD; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FRANCE; HIV INFECTIONS; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; PATIENT CARE MANAGEMENT; PATIENT CARE TEAM;

EID: 84873181351     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31826ebdc7     Document Type: Article

References (29)

1. Bhaskaran K, Hamouda O, Sannes M., et al Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA. 2008;300:51-59.
2. Simard EP, Engels EA Cancer as a cause of death among people with AIDS in the United States. Clin Infect Dis. 2010;51:957-962.
3. Weber R, Sabin CA, Friis-Moller N, et al Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study. Arch Intern Med. 2006;166:1632-1641.
4. Rosenthal E, Pialoux G, Bernard N., et al Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MOR-TAVIC 2003 Study). J Viral Hepat. 2007;14:183-188.
5. Salmon-Ceron D., Lewden C, Morlat P., et al Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. J Hepatol. 2005;42:799-805.
6. Reisler K. High hepatotoxicity rate seen among HAART patients. AIDS Alert. 2001;16:118-119.
7. Sulkowski MS, Thomas DL, Chaisson R.E., Moore RD Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA. 2000;283:74-80.
8. Salmon-Ceron D., Rosenthal E, Lewden C., et al Emerging role of hepa-tocellular carcinoma among liver-related causes of deaths in HIV-infected patients: the French national Mortalite 2005 study. J Hepatol. 2009;50:736-745.
9. Joshi D, O'Grady J, Dieterich D, et al Increasing burden of liver disease in patients with HIV infection. Lancet. 2011;377:1198-1209.
10. Liaw YF, Sung JJ, Chow W.C., et al Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004;351: 1521-1531.
11. Sulkowski M. Hepatocellular carcinoma in HIV-infected patients comes of age: the convergence of epidemiology and treatment effectiveness. J Hepatol. 2009;50:655-658.
12. Berretta M, Garlassi E, Cacopardo B., et al Hepatocellular carcinoma in HIV-infected patients: check early, treat hard. Oncologist. 2011;16: 1258-1269.
13. Brau N, Fox RK, Xiao P, et al Presentation and outcome of hepatocel-lular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study. J Hepatol. 2007;47:527-537.
14. Puoti M, Bruno R, Soriano V., et al Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome. AIDS. 2004;18:2285-2293.
15. Loko MA, Salmon D, Carrieri P., et al The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEP-AVIH): early findings, 2006-2010. BMC Infect Dis. 2010;10:303.
16. Rapport sur la prise en charge médicale des personnes infectées par le VIH. Sous la direction du Pr Patrick Yeni. Recommandations du groupe d'experts avec le soutien du ministèere de la Santé et des Sports. Paris, France: la Documentation française. http://www.sante.gouv.fr/rapport-2010-sur-la-prise-en-charge-medicale-des- personnes-infectees-par-le-vih-sous-la-direction-du-pr-patrick-yeni.html. Accessed August 31, 2012.
17. Bruix J, Sherman M, Llovet J.M., et al Clinical management of hepato-cellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001;35:421-430.
18. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208-1236.
19. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19:329-338.
20. From the Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA. 1993;269:729-730.
21. Ozenne V, Bouattour M, Goutte N., et al Prospective evaluation of the management of hepatocellular carcinoma in the elderly. Dig Liver Dis. 2011;43:1001-1005.
22. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020-1022.
23. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005; 353:487-497.
24. Clifford GM, Rickenbach M, Polesel J., et al Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma. AIDS. 2008; 22:2135-2141.
25. Vibert E, Duclos-Vallee JC, Ghigna M.R., et al Liver transplantation for hepatocellular carcinoma: the impact of human immunodeficiency virus infection. Hepatology. 2011;53:475-482.
26. Kim JE, Kim YS, Rhim H, et al Outcomes of patients with hepato-cellular carcinoma referred for percutaneous radiofrequency ablation at a tertiary center: analysis focused on the feasibility with the use of ultrasonography guidance. Eur J Radiol. 2011;79:e80-e84.
27. Patwardhan V, Paul S, Corey K.E., et al Hepatocellular carcinoma screening rates vary by etiology of cirrhosis and involvement of gastrointestinal sub-specialists. Dig Dis Sci. 2011;56:3316-3322.
28. Tseng PL, Wang JH, Tung H.D., et al Optimal treatment increased survival of hepatocellular carcinoma patients detected with community-based screening. J Gastroenterol Hepatol. 2010;25: 1426-1434.
29. Subramanian A, Sulkowski M, Barin B., et al MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates. Gastroenterology. 2010;138:159-164.